MCCAA Logo
  • MCCAA
  • Blata l-Bajda
  • Head Office
  • +356 2395 2000
  • Consumer Helpline
  • +356 8007 4400
  • Home
  • About Us
    • About the MCCAA
    • Quality Policy
  • Entities
    • Office for Competition
    • Office for Consumer Affairs
    • Technical Regulations Division
    • Standards and Metrology Institute
  • Communication
    • News
    • Events
    • Publications
    • Consultation
    • Procurement
  • Vacancies
  • Tribunal
  • ECC
CONTACT US
MCCAA
  • Home
  • About Us
    • About the MCCAA
    • Quality Policy
  • Entities
    • Office for Competition
    • Office for Consumer Affairs
    • Technical Regulations Division
    • Standards and Metrology Institute
  • Communication
    • News
    • Events
    • Publications
    • Consultation
    • Procurement
  • Vacancies
  • Tribunal
  • ECC
news
Last updated on 26 Mar, 2018

Price reductions for 23 medicines

“For the second time in nine months we are announcing price reductions for a number of medicines and the introduction of new generics in the local market”, stated Parliamentary Secretary for Consumer Protection and Valletta 2018 Deo Debattista.

This was announced at Chemi Pharma Limited, which was recently awarded the certificate of Good Manufacturing Practice for the manufacturing of medicinal products. With a €20 million investment, the Italian company based in Malta and Brazil expanded its operations to Malta.

“The government strengthened the pharmaceutical industry, including specialised and advanced medical fields such as medicines to treat cancer. Today, we are in a facility that manufactures medicines for cancer and is certified by the Malta Medicines Authority. This compliments the government’s strategy, which is inclined to offer the best service to cancer patients. This also proves belief in Malta’s capacity”, noted the Parliamentary Secretary.

With price reductions for 23 medicines which had already been available on the market, consumers will now save up to 40%. These include medicines to treat inflammation, pain and heart disease.

Price reductions were announced along with the introduction of generics and biosimilars, which will enter the market at a reduced price of up to 73%.

The MCCAA Chairperson Helga Pizzuto, and Malta Medicines Authority Chairperson Anthony Serracino Inglott, who along with many stakeholders played a crucial role in price reductions, were also present.

New Generic Medicines/ Biosimilairs

List of Medicine Price Reductions

Recent News

right
Update | Machinery
16 May, 2025
right
Webinar on the new Construction Products Regulation (CPR)
15 May, 2025
right
Web Info Session on the new General Product Safety Regulation
15 May, 2025
right
Notification of Concentration
09 May, 2025
right
Update | Standards
09 May, 2025

Visit us

Mizzi House, National Road, BLATA L-BAJDA, Malta
Opening Hours: Monday to Friday between 8.00am and 12.00pm

Bank Details

Bank name:
Bank of Valletta
IBAN Number:
MT14VALL22013000000040019986609
Swift code:
VALLMTMT

Contact Us

Full Name *
Subject *
Case Type *
Email *
Your Message *
  I consent to having MCCAA store my submitted information so they can respond to my enquiry. For more information about how we process your personal data, please see our privacy policy.
© 2018 MALTA COMPETITION AND CONSUMER AFFAIRS AUTHORITY. ALL RIGHTS RESERVED
WEB DESIGN: BRANDEXPODESIGN
Terms of use | Privacy Policy | Cookie Policy | Freedom of Information | Accessibility Statement | Data Protection Policy
  • Facebook
  • Twitter
  • LinkedIn

Subscribe to our Newsletter

We shall process your personal data in accordingly with our Data Protection Policy. You have the right to unsubscribe from our list by clicking here, following which your email address will be permanently deleted from our database.